BTIG on Medline Inc (MDLN): 'Overcomes Adversity and Expands Regional Footprint by 45%'

July 8, 2026 4:18 PM

BTIG analyst David Larsen reiterated a Buy rating and $55.00 price target on Medline Inc (NASDAQ: MDLN).The analyst comments "MDLN ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found